Vnitr Lek 2010, 56(2):106-110

Prevalence of rheumatic manifestations and non-organ specific autoimmunity in patients with autoimmune thyreopathy

K. Benhatchi1,*, I. Lazúrová1, D. Kozáková2, J. Rovenský2
1 I. interná klinika Lekárskej fakulty UPJŠ a FN L. Pasteura Košice, Slovenská republika, prednostka prof. MUDr. Ivica Lazúrová, CSc.
2 Národný ústav reumatických chorôb Piešťany, Slovenská republika, riaditeľ prof. MUDr. Jozef Rovenský, DrSc., FRCP

Introduction: A variety of rheumatic manifestations (RM) has been described in association with autoimmune thyroiditis (AIT). In the past, most of these manifestations were attributed to the underlying thyroid dysfunction, in particular hypothyroidism. AIT is often associated with non-organ specific autoimmunity. Increased prevalence of non-organ specific autoantibodies in patients with AIT without any evidence of rhemautic manifestations is clinically unclear. Aim of this study was to find out the frequency of apperance of non-organ specific antibodies in serum in patients with AIT and prevalence of RM (arthralgia/arthitis).

Patients and methods: The group consisted of 80 patients with diagnosis AIT. The diagnosis of AIT was made according to established criteria. This diagnosis was primarily based on laboratory markers including thyroid hormone levels (TSH, fT4, fT3), the detection of antithyroid antibodies (anti-TPO, anti-TG, anti-RTSH antibodies) and on ultrasound examination (imaging signs of thyroid autoimmunity) of thyroidal gland. None of the above patients had a history of systemic autoimmune disorders. In the group of patients with AIT we evaluated the prevalence of non-organ specific antibodies (ANA/Hep 2, ENA scr., SSA, SSB, nRNP, dsDNA, DNP, RF, ACLA scr., ANCA/MPO, ANCA/PR3) and presence of RM (arthritis/arthralgia). The control group consisted of 34 patients with no overt history of AIT or systemic autoimmune disorders.

Results: In the group of patients with AIT ANA positivity was found in 36/80 (45%) patients compared with 5/34 (14.7%) in healthy controls (p < 0.05). The prevalence of ANA autoantibodies was significantly higher in patients with AIT than in healthy controls. Other levels of non-organ specific antibodies (ENA scr., SSA, SSB, nRNP, dsDNA, DNP, RF, ACLA scr., ANCA/MPO, ANCA/PR3) were not significantly different among patients with AIT and healthy controls. 40/80 (50%) of patients with AIT had artralgia compared with 7/34 (20.6%) in healthy controls (p < 0.05) and 19/80 (23.75%) of patients with AIT had arthritis compared with 1/34 (2.9%) in healthy controls (p < 0.05). The prevalence of RM (arthralgia and arthritis) in group of patients with AIT was significantly higher than in healthy controls.

Conclusion: The prevalence of ANA autoantibodies and RM (arthralgia/arthritis - both) was significantly higher in patients with AIT than in healthy controls.

Keywords: autoimmune thyreopathy; non-organ specific autoantibodies; connective tissue diseases; rheumatic manifestations

Received: September 27, 2009; Accepted: November 16, 2009; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Benhatchi K, Lazúrová I, Kozáková D, Rovenský J. Prevalence of rheumatic manifestations and non-organ specific autoimmunity in patients with autoimmune thyreopathy. Vnitr Lek. 2010;56(2):106-110.
Download citation

References

  1. Osundeko O, Hasinski S, Rose L. Anti-cardiolipin antibodies in Hashimoto's disease. Endocr Pract 2001; 7: 181-183. Go to original source... Go to PubMed...
  2. Punzi L, Batterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71: 275-283. Go to original source... Go to PubMed...
  3. Morita S, Arima T, Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid disease. J Clin Endocrinol Metab 1995; 80: 1203-1206. Go to original source...
  4. Guerin V, Bene MC, Barbe F et al. Stigmates autoimmunitaires thyroidiens au cours de la polyarthrite rhumatoide. Rev Rhum 1987; 54: 438.
  5. Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P et al. Presence of systematic autoimmune disorders in patiens with autoimmune thyroid diseases. Ann Rheum Dis 2004; 63: 1159-1161. Go to original source... Go to PubMed...
  6. Šterzl I, Hrdá P, Matucha P et al. Polyglandulární aktivace autoimunity jako projev subklinických endokrinopatií. Čas Lék Čes 2007; 146: 256-261.
  7. Guerin V, Prestat F, Bene MC et al. Prevalence of non-thyroid autoantibodies in autoimmune dysthyroidies. Ann Endocrinol 1989; 50: 477-482.
  8. Weetman A. Non-thyroid autoantibodies in autoimmune thyroid disease. Best Practice and Research Clin Endocrinology and Metabolism 2005; 19: 17-32. Go to original source... Go to PubMed...
  9. Hansen BU, Ericsson UB, Henricsson V et al. Autoimmune thyroiditis and primary Sjogren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 1991; 9: 137-141. Go to original source... Go to PubMed...
  10. Katakura M, Yamada T, Aizawa T et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Grave's disease. J Clin Endocrinol Metab 1987; 64: 405-408. Go to original source... Go to PubMed...
  11. McDermott MT, West SG, Emlen JW et al. Antideoxyribonucleic acid antibodies in Grave's disease. J Clin Endocrinol Metab 1990; 71: 509-511. Go to original source... Go to PubMed...
  12. Baethge BA, Levine SN, Wolf RE. Antibodies to nuclear antigens in Grav's disease. J Clin Endocrinol Metab 1988; 66: 485-488. Go to original source... Go to PubMed...
  13. Loviselli A, Velluzzi F, Pala R et al. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33-36. Go to original source... Go to PubMed...
  14. Paggi A, Caccavo D, Ferri GM et al. Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol 1994; 40: 329-333. Go to original source... Go to PubMed...
  15. Petri M, Karlson EW, Cooper DS et al. Antibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 1991; 18: 1529-1531. Go to PubMed...
  16. Punzi L, Michelotto M, Pianon M et al. Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymfocytic thyroiditis. Clin Exp Rheumatol 1997; 15: 373-380. Go to PubMed...
  17. Blake DR, McGregor AM, Stansfield E et al. Antithyroid-antibodies activity in the synovial fluid of patients with various arthritides. Lancet 1979; 2: 224-226. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.